119 related articles for article (PubMed ID: 31948344)
1. Correlation between
Geng B; Li S; Zhou J; Feng G
Phlebology; 2020 Aug; 35(7):472-479. PubMed ID: 31948344
[TBL] [Abstract][Full Text] [Related]
2. Genetic association between plasminogen activator inhibitor-1 rs1799889 polymorphism and venous thromboembolism: Evidence from a comprehensive meta-analysis.
Huang G; Wang P; Li T; Deng X
Clin Cardiol; 2019 Dec; 42(12):1232-1238. PubMed ID: 31701558
[TBL] [Abstract][Full Text] [Related]
3. The roles of PAI-1 gene polymorphisms in atherosclerotic diseases: A systematic review and meta-analysis involving 149,908 subjects.
Liu Y; Cheng J; Guo X; Mo J; Gao B; Zhou H; Wu Y; Li Z
Gene; 2018 Oct; 673():167-173. PubMed ID: 29908999
[TBL] [Abstract][Full Text] [Related]
4. Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and risk of venous thromboembolism: a meta-analysis.
Wang J; Wang C; Chen N; Shu C; Guo X; He Y; Zhou Y
Thromb Res; 2014 Dec; 134(6):1241-8. PubMed ID: 25450536
[TBL] [Abstract][Full Text] [Related]
5. Plasminogen activator inhibitor-1 (PAI-1) 4G/5G promoter polymorphisms and risk of venous thromboembolism - a meta-analysis and systematic review.
Zhang Q; Jin Y; Li X; Peng X; Peng N; Song J; Xu M
Vasa; 2020 Mar; 49(2):141-146. PubMed ID: 31920171
[No Abstract] [Full Text] [Related]
6. Correlations between methylenetetrahydrofolate reductase gene polymorphisms and venous thromboembolism: A meta-analysis of 99 genetic association studies.
Zeng J; Zeng Q
Eur J Prev Cardiol; 2019 Jan; 26(2):120-134. PubMed ID: 30466296
[TBL] [Abstract][Full Text] [Related]
7. Association of PAI-1 rs1799889 Polymorphism with Susceptibility to Ischemic Stroke: a Huge Meta-Analysis based on 44 Studies.
Jafari M; Jarahzadeh MH; Dastgheib SA; Seifi-Shalamzari N; Raee-Ezzabadi A; Sadeghizadeh-Yazdi J; Akbarian E; Neamatzadeh H
Acta Medica (Hradec Kralove); 2020; 63(1):31-42. PubMed ID: 32422114
[TBL] [Abstract][Full Text] [Related]
8. PAI-1 Polymorphisms Have Significant Associations With Cancer Risk, Especially Feminine Cancer.
Wang J; Peng Y; Guo H; Li C
Technol Cancer Res Treat; 2021; 20():15330338211037813. PubMed ID: 34521295
[TBL] [Abstract][Full Text] [Related]
9. Association of SERPINE1 rs1799889 polymorphism with arterial ischemic stroke in children: a systematic review and meta-analysis.
Bahrami R; Dastgheib SA; Mirjalili H; Setayesh S; Shaker SH; Mirjalili SR; Noorishadkam M; Neamatzadeh H
Nucleosides Nucleotides Nucleic Acids; 2021; 40(10):1018-1035. PubMed ID: 34429017
[TBL] [Abstract][Full Text] [Related]
10. The correlation analysis of tumor necrosis factor-alpha-308G/A polymorphism and venous thromboembolism risk: A meta-analysis.
Gao Q; Zhang P; Wang W; Ma H; Tong Y; Zhang J; Lu Z
Phlebology; 2016 Oct; 31(9):625-31. PubMed ID: 26405065
[TBL] [Abstract][Full Text] [Related]
11. [The investigation of angiotensin converting enzyme I/D and plasminogen activator inhibitor-1 4G/5G polymorphisms in venous thromboembolism patients].
Kaya H; Karkucak M; Salifoğlu H; Torun D; Kozan S; Tunca Y
Tuberk Toraks; 2013; 61(2):88-95. PubMed ID: 23875585
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphism of the plasminogen activator inhibitor-1 is associated with an increased risk of endometrial cancer.
Su CK; Yeh KT; Yeh CB; Wang PH; Ho ES; Chou MC; Liu KC; Yang SF; Yi YC
J Surg Oncol; 2011 Dec; 104(7):755-9. PubMed ID: 21761413
[TBL] [Abstract][Full Text] [Related]
13. Association Between Plasminogen Activator Inhibitor-1 Genetic Polymorphisms and Stroke Susceptibility.
Hu X; Zan X; Xie Z; Li Y; Lin S; Li H; You C
Mol Neurobiol; 2017 Jan; 54(1):328-341. PubMed ID: 26742513
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis of the association between plasminogen activator inhibitor-1 4G/5G polymorphism and recurrent pregnancy loss.
Li X; Liu Y; Zhang R; Tan J; Chen L; Liu Y
Med Sci Monit; 2015 Apr; 21():1051-6. PubMed ID: 25862335
[TBL] [Abstract][Full Text] [Related]
15. Significant associations of PAI-1 genetic polymorphisms with osteonecrosis of the femoral head.
Kim H; Cho C; Cho Y; Cho S; Yoon K; Kim K
BMC Musculoskelet Disord; 2011 Jul; 12():160. PubMed ID: 21752301
[TBL] [Abstract][Full Text] [Related]
16. Association between plasminogen activator inhibitor-1 gene polymorphisms and susceptibility to Parkinson's disease in Chinese patients.
Xu Q; Lai Q; Wang J; Zhuang L; Cheng L; Mo Y; Liu L; Zhao Z; Zhang Y; Weng S; Qiao S
Acta Neurol Belg; 2022 Dec; 122(6):1557-1566. PubMed ID: 34845645
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the plasminogen activator inhibitor-1 4G/5G gene polymorphism in females with venous thromboembolism during pregnancy or spontaneous abortion.
Schenk JF; Stephan B; Zewinger S; Speer T; Pindur G
Clin Hemorheol Microcirc; 2008; 39(1-4):329-32. PubMed ID: 18503142
[TBL] [Abstract][Full Text] [Related]
18. The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolism.
Stegnar M; Uhrin P; Peternel P; Mavri A; Salobir-Pajnic B; Stare J; Binder BR
Thromb Haemost; 1998 May; 79(5):975-9. PubMed ID: 9609232
[TBL] [Abstract][Full Text] [Related]
19. The susceptibility of SERPINE1 rs1799889 SNP in diabetic vascular complications: a meta-analysis of fifty-one case-control studies.
Chen J; Zhai C; Wang Z; Li R; Wu W; Hou K; Alzogool M; Wang Y; Cong H
BMC Endocr Disord; 2021 Sep; 21(1):195. PubMed ID: 34592988
[TBL] [Abstract][Full Text] [Related]
20. Association between FSAP 1601G
Da L; Jiahui Z; Xiaoqiang L
Phlebology; 2020 Jun; 35(5):345-353. PubMed ID: 31635523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
